Rocket Lab Clears HSR, Files S-4 and FCC Applications for Iridium Acquisition
IRDM has more than doubled off its 52-week low of $15.645.
Summary
Rocket Lab cleared U.S. antitrust review, filed its S-4 and FCC applications, and outlined financing plans for its acquisition of Iridium.
Key Events · M&A and Partnerships · IRDM
-
HSR Waiting Period Expired
The U.S. antitrust waiting period under HSR expired at 11:59 p.m. ET on August 12, 2026, clearing a major regulatory hurdle for the acquisition.
-
Form S-4 Filed with SEC
Rocket Lab filed its registration statement on Form S-4 on August 13, 2026, to register the shares to be issued to Iridium shareholders.
-
FCC Applications Filed
Rocket Lab and Iridium filed applications with the FCC on August 10, 2026, seeking consent to transfer control of Iridium's licenses.
-
Financing Strategy Update
Rocket Lab announced a new at-the-market equity program and plans to amend Iridium's $1.775 billion term loan to reduce reliance on the $3.6 billion bridge facility.
Analysis · IRDM · Technology
A major antitrust hurdle has been cleared: the HSR waiting period for Rocket Lab's acquisition of Iridium expired on August 12, 2026. The company also filed its Form S-4 registration statement with the SEC and FCC applications to transfer Iridium's licenses. These are critical steps toward closing the $54 per share deal. Additionally, Rocket Lab disclosed a new at-the-market equity program and plans to amend Iridium's $1.775 billion term loan to reduce reliance on a $3.6 billion bridge facility. The regulatory clearances and financing strategy reduce deal risk and clarify the path to completion.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IRDM was trading at $49.90 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $15.65 to $57.18. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.